SICEM 2023

Satellite symposium 1 [LG Chem] Day 1, Thursday, October 26, 19:00-20:00 / Room 3 (3F)

Chairpersons : Jeong Hyun Park (Inje University, Korea), Sung-Hoon Kim (MizMedi Hospital, Korea)

	19:00-19:25	Gemigliptin + dapagliflozin: optimal combination for holistic diabetes treatment Dughyun Choi (Soonchunhyang University, Korea)
	19:25-19:50	Optimal diabetes management with evidence-based 'Zemidapa®' Soree Ryang (Pusan National University, Korea)
	19:50-20:00	Discussion

Satellite symposium 2 [BI-LLY] (K) Day 1, Thursday, October 26, 19:00-20:00 / Room 4 (3F)

Chairpersons : Kang Seo Park (Eulji University, Korea), Seok Ki Yun (Cheonan Endo Medical Clinic, Korea)

	19:00-19:25	Early intervention of type 2 diabetic patient considering cardio-renal-metabolic system Jae-Seung Yun (The Catholic University of Korea, Korea)
	19:25-19:50	New paradigm: benefits of combination treatment of SGLT2 inhibitor & DPP-4 inhibitor Ju Hee Lee (Chungnam National University, Korea)
	19:50-20:00	Discussion

Satellite symposium 3 [Dong-A ST] (K) Day 2, Friday, October 27, 19:00-20:00 / Room 1 (3F)

Chairpersons : Ie Byung Park (Gachon University, Korea), Soon Hee Lee (Inje University, Korea)

	19:00-19:25	Early treatment of type 2 diabetic patients considering cardiorenal function Jung Hwan Park (Hanyang University, Korea)
	19:25-19:50	What's new in drug treatment of diabetes So-Hun Kim (Inha University, Korea)
	19:50-20:00	Discussion

Satellite symposium 4 [Daewoong Pharmaceutical] (K) Day 2, Friday, October 27, 19:00-20:00 / Room 2 (3F)

Chairpersons : Kyungwan Min (Eulji University, Korea), Seok Won Park (Yonsei University, Korea)

	19:00-19:25	The emergence of SGLT2 inhibitor and Envlo®'s first step Sin Gon Kim (Korea University, Korea)
	19:25-19:50	Novel enhanced SGLT2 inhibitor Sung Hee Choi (Seoul National University, Korea)
	19:50-20:00	Discussion

Scientific program